Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies.
Hamm CA, Baumgärtner GL, Padhani AR, Froböse KP, Dräger F, Beetz NL, Savic LJ, Posch H, Lenk J, Schallenberg S, Maxeiner A, Cash H, Günzel K, Hamm B, Asbach P, Penzkofer T.
Hamm CA, et al. Among authors: lenk j.
Eur Radiol. 2024 Oct;34(10):6229-6240. doi: 10.1007/s00330-024-10700-z. Epub 2024 Mar 28.
Eur Radiol. 2024.
PMID: 38538841
Free PMC article.